Skip to main content

Advertisement

Table 1 Patients included in the study

From: Adipose tissue derived stem cells: in vitro and in vivo analysis of a standard and three commercially available cell-assisted lipotransfer techniques

  Standard lipoaspirate ASC-enriched lipoaspirate Statistical significance ASC-enriched lipoaspirate technique  
Cytori Lipokit Fastem
Clinical features       
n (%) 16 (44.4%) 20 (55%)   9 (25%) 5 (13.8%) 6 (16.7%)
Age (years) 49.5 (21 to 71) 48 (19 to 74) P = 0.8370 46 (41 to 70) 52 (41 to 57) 52 (19 to 74)
BMI (kg/m2) 22.35 (19.36 to 30.3) 21.4 (19.8 to 32.8) P = 0.7520 21.30 (20.58 to 30.5) 22.19 (20 to 32.8) 21.20 (19.8 to 24.4)
Co-morbidities 0 (0.0%) 2 (10.0%) P = 0.4921 1 (11.1%) 1 (20.0%) 0 (0.0%)
Previous surgical procedure
Mastectomy 14 (87.50%) 16 (80.00%) P = 0.6722 8 (89%) 5 (100%) 3 (50%)
Quadrantectomy 1 (6.25%) 2 (10.00%) P = 1.0000 1 (11.1%) 0 (0.00%) 1 (16.7%)
None (congenital malformation) 1 (6.25%) 2 (10.00%) P = 1.0000 0 (0.00%) 0 (0.00%) 2 (33.3%)
Donor area       
Abdomen 5 (31.25%) 1 (5.00%) P = 0.0689 0 (0.00%) 0 (0.00%) 1 (16.7%)
Hips 7 (43.75%) 7 (35.00%) chi-q = 0.5926 3 (22.2%) 3 (60%) 1 (16.7%)
Trochanteric region 2 (12.50%) 2 (10.00%) P = 1.0000 1 (11.1%) 0 (0.00%) 1 (16.7%)
Abdomen and hips 2 (12.50%) 4 (20%) P = 0.6722 1 (11.1%) 2 (40%) 1 (16.7%)
Hips and trochanteric region 0 (0.00%) 4 (20%) P = 0.1131 3 (22.2%) 0 (0.00%) 1 (16.7%)
Abdomen and trochanteric region 0 (0.00%) 1 (5.00%) P = 1.0000 0 (0.00%) 0 (0.00%) 1 (16.7%)
Abdomen. hips and trochanteric region 0 (0.00%) 1 (5.00%) P = 1.0000 1 (11.1%) 0 (0.00%) 0 (0.00%)
Amount of solution infiltrated (cm3) 95 (54 to 160) 143 (60 to 230) P = 0.0540 158 (75 to 230) 145 (60 to 175) 85 (75 to 165)
Adjuvant therapies
None 6 (37.5%) 11 (55%) P = 0.3351 5 (55.6%) 2 (40%) 4 (66.7%)
RT 1 (6.25%) 3 (15.00%) P = 0.6129 1 (11.1%) 1 (20%) 1 (16.7%)
CT 7 (43.75%) 3 (15.00%) P = 0.0732 1 (11.1%) 2 (40%) 0 (0.00%)
RT and CT 2 (12.50%) 3 (15.00%) P = 1.0000 2 (22.2%) 0 (0.00%) 1 (16.7%)
Hormonal therapies 7 (43.75%) 12 (60.00%) chi-q = 0.3318 6 (67%) 4 (80%) 2 (33.3%)
  1. Data presented as median (range) or n (%). ASC, adipose stem cell; BMI, body mass index; CT, chemotherapy; Cytori, Cytori Celution System (Cytori Ltd., Deeside, UK) [25]; Fastem, Fastem Corios (CORIOS Soc. Coop, San Giuliano Milanese (MI), Italy); Lipokit, Lipokit Medikhan System (Medikan International Inc, Pusan, Korea) [26]; RT, radiotherapy.